What is Kinaset Therapeutics worth?
$186.0Mlast known valuation
Kinaset Therapeutics last raised $103.0M in its Later Stage VC (Series B) (Jan 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Kinaset Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Later Stage VC (Series B) | $103.0M | ▮ | ▮ |
| Jul 2022 | Early Stage VC | $28.5M | ▮ | ▮ |
| Jul 2020 | Seed Round | $1.5M | ▮ | ▮ |
How Kinaset Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Kinaset Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Kinaset Therapeutics worth?
- Kinaset Therapeutics's last known valuation is $186.0M.
- How much has Kinaset Therapeutics raised?
- Kinaset Therapeutics has raised $143.0M in total funding across 3 recorded rounds.
- When did Kinaset Therapeutics last raise?
- Kinaset Therapeutics last raised in Jan 2026 (Later Stage VC (Series B)), raising $103.0M.